Cover: The Link Between Public and Private Insurance and HIV-related Mortality

The Link Between Public and Private Insurance and HIV-related Mortality

Published in: NBER Working Paper No. W9346, Nov. 2002

by Jay Bhattacharya, Dana P. Goldman, Neeraj Sood

Read More

Access further information on this document at papers.nber.org

This article was published outside of RAND. The full text of the article can be found at the link above.

Abstract

As policymakers consider expanding insurance coverage for HIV individuals, it is useful to ask if insurance has any affect on health outcomes; and, if so, whether public insurance is as efficacious as private insurance in preventing premature deaths among HIV patients. Using data from a nationally representative cohort of HIV-infected persons receiving regular medical care, we estimate the impact of different types of insurance on mortality in this population. We find that ignoring observed and unobserved health status leads one to conclude (misleadingly) that insurance may not be protective for HIV patients. After accounting for observed and unobserved heterogeneity, insurance does protect against premature death, but private insurance is more effective than public coverage. The better outcomes associated with private insurance are attributable to the more restrictive prescription drug policies of Medicaid

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.